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Cannabis and caries - does regular cannabis use increase the risk
of caries in cigarette smokers
Abstract
Summary The use of cannabis by adolescents in Switzerland has almost doubled in the past decade.
Empirical observations in private dental practices indicate that cannabis users have more carious lesions
than those who do not use cannabis. The aim of this study was to investigate the hypothesis that regular
cannabis use increases the risk of caries because of hyposalivation or lifestyle. Forty-three regular
cannabis users were enrolled in the test group and 42 tobacco smokers were used as a negative control
group. All subjects were 18-25 years old. Data were obtained using a standardized questionnaire and a
clinical examination. There was no significant difference between groups in decayed and filled surfaces
(DFS), saliva flow rate and plaque and gingival indices. The cannabis group had, however, significantly
higher DS (decayed surface) values (p = 0.0001) and significantly lower frequencies of daily tooth
brushing and dental control visits (p < 0.0001) than the control group. Additionally, the cannabis group
reported a significantly higher consumption of sugarcontaining beverages than the control group (p =
0.0078). To obtain more objective data relations, the DS values of male cannabis users were also
compared with those of Swiss military recruits found in another study. The cannabis users had more
caries on smooth surfaces than the military recruits. Although comparison with epidemiological data
suggested that the prevalence of caries on smooth surfaces is elevated in cannabis users, DFS data
indicated that cannabis users do not have an increased risk of caries. Lifestyle combined with short-term
hyposalivation after delta-9-tetrahydrocannabinol consumption is the most probable cause of the high
prevalence of caries on smooth surfaces in cannabis users. Further studies are needed to investigate the
effects of cannabis use on oral health.
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Summary 
The use of cannabis by adolescents in Switzerland has almost doubled in the past 
decade. Empirical observations in private dental practices indicate that cannabis users 
have more carious lesions than those who do not use cannabis. The aim of this study 
was to investigate the hypothesis that regular cannabis use increases the risk of caries 
because of hyposalivation or lifestyle. 
 
Forty-three regular cannabis users were enrolled in the test group and 42 tobacco 
smokers were used as a negative control group. All subjects were 18–25 years old. Data 
were obtained using a standardized questionnaire and a clinical examination. 
 
There was no significant difference between groups in decayed and filled surfaces 
(DFS), saliva flow rate and plaque- and gingival indices. The cannabis group had,  
however, significantly higher DS (decayed surface) values (p = 0.0001) and 
significantly lower frequencies of daily tooth brushing and dental control visits (p < 
0.0001) than the control group. Additionally, the cannabis group reported a significantly 
higher consumption of sugar-containing beverages than the control group (p = 0.0078). 
To obtain more objective data relations, the DS values of male cannabis users were also 
compared with those of Swiss military recruits found in another study. The cannabis 
users had more caries on smooth surfaces than the military recruits. 
 
Although comparison with epidemiological data suggested that the prevalence of caries 
on smooth surfaces is elevated in cannabis users, DFS data indicated that cannabis users 
do not have an increased risk of caries. Lifestyle combined with short-term 
hyposalivation after delta-9-tetrahydrocannabinol consumption is the most probable 
cause of the high prevalence of caries on smooth surfaces in cannabis users. Further 
studies are needed to investigate the effects of cannabis use on oral health. 
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Introduction 
The use of cannabis is common in Europe. One out of five adults has used cannabis at 
least once in his or her lifetime. Once-in-a-lifetime use of cannabis is particularly 
prevalent among younger members of the population because 44% of 15–34-year-olds 
report using cannabis once. Estimates of the actual use of cannabis (use during the past 
12 months) in 15–34-year-olds in Europe vary from 5%–20%. On a global basis, regular 
use of cannabis is highest in Canada and Spain (>15%) and Switzerland (18.3%) 
(European Monitoring Centre for Drugs and Drug Addiction [EMCDDA] 2002, 
BUNDESAMT FÜR STATISTIK 2004). 
 
During the past decade, regular cannabis use by young people (15–24 years old) has 
increased in Switzerland. From 1992 to 2002, cannabis consumption almost doubled 
(from 9.8% to 16.3% in males and from 4.3% to 7.7% in females; BUNDESAMT FÜR 
STATISTIK 2004. Among 15–16-year-old Swiss pupils, 49.9% of males and 39.1% of 
females had at least a once-in-a-lifetime experience with cannabis. The probability of 
young people using cannabis has increased since 1986. Males are more likely to use 
cannabis than females (SCHMID ET AL. 2003); 41% of male and 33% of female 14–16-
year-old Swiss teenagers reported an experience with cannabis. Twenty percent of 
pupils reported using cannabis in the previous 30 days, 6.5% had used cannabis once or 
twice, 9.8% had used cannabis 3 to 39 times and 2.2% had used cannabis 40 times or 
more (split by gender: males 3.1%, females 1.3%) (GMEL ET AL. 2003). 
 
Narring and coworkers differentiated between genders and between students and 
apprentices. Among 20-year-old males, 60% of apprentices and 73% of students had at 
least a once-in-a-lifetime-experience with cannabis. The majority of young people in 
Switzerland between the ages of 16 and 20 has used cannabis occasionally and 4% of 
females and 13% of males use it on a daily basis (NARRING ET AL. 2003). 
 
The cannabis plant, Cannabis sativa, originated in central Asia and was introduced into 
India in the 8th century BC, where it was used for religious ceremonies and medical 
purposes. Subsequently, cannabis was widely used to treat gastric complaints, 
headaches, coughing, hepatitis, gout, “hard tumors”, tetanus and rabies. In the 20th 
century, the pharmaceutical importance of cannabis diminished because of the invention 
of drugs and vaccinations specific for many of the above-mentioned illnesses. 
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Cannabis contains 483 natural substances belonging to 19 classes of chemicals. 
Cannabis contains 66 cannabinoids. The most potent psychoactive substance is delta-9-
tetrahydrocannabinol (THC). The effects of most of these substances on the human 
body are unknown. Although cannabis has medical potential, further knowledge on its 
biological effects and on appropriate forms of application is needed (GROTENHERMEN  
2001). 
 
Cannabis is inhaled by smoking and is often mixed with tobacco. It can also be added to 
food. Cannabis is consumed in three main forms: marijuana (dried weeds and 
blossoms), hashish (pollen and resin) and hashish oil. The concentration of THC is 
9.6% in marijuana, 14.8% in hashish and 66.4% in hashish oil (SCHLÄPFER 2005). The 
most common forms of cannabis use in Switzerland are marijuana (44%), hashish 
(22%) and a mixture of both (34%) (MÜLLER ET AL. 2001). When cannabis is smoked, 
effects occur within 2 to 3 minutes, peak within 10 to 20 minutes and diminish after 2 
hours (DARLING 2003). 
 
Cannabis smoke contains carcinogens similar to those in tobacco smoke but contains no 
nicotine (ELSOHLY 2001). One marijuana joint deposits four times as much tar in the 
respiratory tract as a tobacco cigarette of the same weight (TASHKIN 1999). According 
to HALL & MACPHEE  (2002) “the experimental and epidemiological evidence of the 
cancer risks of cannabis use is still too meagre to warrant strong conclusions, but it 
raises concerns that for reasons of prudence should be communicated to cannabis users 
on public health grounds.” 
 
The THCs of synthetic, biological or endogenous cannabinoids exert their effects 
throughout the body by interacting with receptors of the cannabinoid system, which was 
first identified in invertebrates and mammals. The human endogenous cannabinoid is 
called anandamide; its effects are similar to those of THC but are much weaker. 
Neuronal receptors called CB1s are located in the central nervous system (cerebellum, 
frontal cerebrum and hippocampus). As there are very few CB1s in the brainstem, vital 
functions are not affected by the use of cannabis. Therefore, a lethal dose of cannabis is 
improbable. Nevertheless, cannabis abuse has many adverse psychological and 
physiological effects (Table I). 
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The effects of cannabis are complex. Adolescents, in whom the nervous system is still 
developing, are especially vulnerable (EHRENREICH ET AL. 1999, WILSON and NICHOLL 
2001). Hyposalivation is of great interest to dental professionals for its negative effect 
on oral health (IMFELD 1984). 
 
A search of the PubMed database, a service of the U.S. National Library of Medicine 
and the National Institutes of Health, using “cannabis” or “marijuana” and “caries” as 
key words returned only seven references. CHO (2005) and DARLING and ARENDORF 
(1992) reviewed the scientific literature on the effects of cannabis on oral health, 
including dry mouth. MADINIER (2002) discussed the illicit drugs that are used by 
regular drug users when they have toothache. PALLASCH  (1987) described the effects of 
drug abuse on the oral cavity in general. DI CUGNO (1979) studied vitamin levels and 
oral status in 51 amphetamine and cannabis users in Buenos Aires, Argentina. He 
mentioned that xerostomia was a side effect of these drugs, but did not report on how 
this result was obtained. SILVERSTEIN ET AL. (1978) investigated a group of 206 people 
living in a commune in the USA in which cannabis and tobacco were used in addition to 
other drugs. The control group consisted of 68 people who did not smoke tobacco and 
did not live in a commune. The seventh report identified by the PubMed search, 
Phytonicides in Dentistry by SOLDAN (1953), was published in the Czech language and 
an English abstract was not available. 
 
To our knowledge, our study is the first clinical investigation on the specific effects of 
cannabis use on oral health in smokers. The hypothesis tested in this study, i.e., that 
regular cannabis use increases the risk of caries, originated from empirical experience in 
dental private practice. Potential explanations are that the increased risk of caries is 
caused by THC-associated hyposalivation or lifestyle. 
 
Material & Methods 
The study was approved by the SPUK ethics commission (Spezialisierte 
Unterkommission der Kantonalen Ethikkommssion, Zürich) in April 2005 [StV 05/04]. 
Informed consent was obtained from all participants. 
 
According to Article 15 of the Swiss Health Statute, the investigators were not 
requested to report the subjects who used or abused cannabis to the police, and all 
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information was confidentially because there was no evidence of delinquency among 
the subjects (BUNDESGESETZ ÜBER BETÄUBUNGSMITTEL UND PSYCHOTROPE STOFFE 
812.121 (BetmG) 2007). 
Participants were recruited through advertisements in free daily newspapers, short 
presentations at high schools and vocational schools, flyers and regional radio appeals. 
Participants were also encouraged to recruit their friends. 
Cannabis users were recruited before defining the inclusion criteria for the control group 
because neither clinical data nor habits of cannabis users were well known. When 
examining the test group it was observed that all of them additionally smoked tobacco 
on a regular basis (at least ten cigarettes per day). In order to get similar group 
parameters with cannabis use as the main difference, tobacco use was defined as an 
inclusion criterion for the control group as well. If non-smokers had been chosen as a 
control group tobacco smoking would have become a confounding factor for the 
evaluation of the effect of cannabis use. 
Inclusion criteria for the test group (cannabis users, group A): 
(i) age 18 to 25 years, 
(ii) good general health, 
(iii) cannabis use (at least once per week), 
(iv) duration of cannabis use (at least two years). 
Inclusion criteria for the control group (cannabis nonusers, group B): 
(i) age 18 to 25 years, 
(ii) good general health, 
(iii) no cannabis use, 
(iv) tobacco use (at least ten cigarettes per day), 
(v) duration of tobacco use (at least two years). 
 
Exclusion criteria for both groups: 
(i) medical conditions affecting the oral cavity, 
(ii) use of other illicit drugs, 
(iii) pregnancy. 
 
All participants completed a questionnaire to obtain data on demographics, 
psychological history, health status, dietary habits and daily oral hygiene. The cannabis 
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group was also questioned about the frequency of drug use, their favorite form of 
cannabis, the age at which they first experienced cannabis, whether they experienced a 
dry mouth after smoking cannabis, whether they would change their drug habits if they 
were associated with an increased risk of caries, and whether they would stop using 
cannabis if it was associated with an increased risk of developing cancer. 
 
The participants were clinically examined by one researcher (M.S.). Two bitewing 
radiographs were taken. These were assessed by a second researcher (C.I.). The oral 
mucosa was investigated for abnormalities. Plaque and gingival indices (LÖE 1967) 
were measured buccally in the 1st and 4th quadrants and orally in the 2nd and 3rd 
quadrants. The level of decayed and filled surfaces (DFSs) (KLEIN ET AL. 1938) was 
determined. The M (missed surfaces) factor was omitted because third molars and teeth 
extracted for orthodontic reasons were not included in the analysis. Decayed lesions (D) 
were defined as dentine lesions detected radiographically or clinically. The DFS data of 
group A was compared with DFS data obtained from an epidemiological survey of 
Swiss military recruits in 2006 (MENGHINI et al. unpublished). The stimulated saliva 
flow rate was measured using a high-precision scale and saliva pH and buffer capacity 
were measured using an indicator system (pH 6.4–8.0; Merck KGaA, D-64271 
Darmstadt) and a buffer analysis kit (CRT, Ivoclar-Vivadent, FL-9494 Schaan), 
respectively. 
 
Participants were not charged for the dental examination and were given duplicates of 
the bitewing radiographs. All participants received detailed information about their oral 
status and individual advice on prophylaxis (fluoride, oral hygiene, and nutrition). 
Patients were informed about the effects of regular oral hygiene, fluoridated toothpaste 
and gel and effective tooth brushing methods. If the patients reported unfavorable 
dietary habits (e.g., intake of beverages or food with a high sugar content), they were 
informed as to how their diet could be improved. 
 
Urine samples were not obtained from the participants because self-reported cannabis 
use is not distorted by denial tendencies (GMEL 1998). 
Statistical analysis 
As groups A and B were not paired in respect of gender, the data were only analyzed 
descriptively. Differences between the control and test groups within genders were 
analyzed using the Mann–Witney and chi-squared tests. 
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Results 
Gender, age, education and tobacco use 
Forty-three participants were included in the test group (cannabis users, group A) and 
42 were included in the control group (tobacco smokers, group B). In group A, 28 
subjects were male (65%) and 15 were female (35%); in group B, 14 subjects were male 
(33%) and 28 were female (67%). The average age of participants was 22.6 years for 
group A and 23.2 years for group B. 
 
Seventy percent of subjects in group A and 60% of subjects in group B were 
apprentices; 18% of subjects in group A and 33% of subjects in group B attended 
university or college; 12% of subjects in group A and 7% of subjects in group B were 
neither apprentices nor students. 
 
Fifty percent of subjects in group A and 56% of subjects in group B smoked 10 
cigarettes per day; 50% of subjects in group A and 33% of subjects in group B smoked 
10–20 cigarettes per day; 9% of subjects in group B smoked more than 20 cigarettes per 
day. 
Frequency of daily tooth brushing 
The frequency of daily tooth brushing is shown in Table II. Group A brushed 
significantly less than group B (p < 0.0001, chi-squared test). 
Frequency of dental visits 
Twenty-one percent of subjects in group A and 74% of subjects in group B visited their 
dentist annually. Reasons for irregular or rare visits given by the remaining 79% of 
subjects in group A were anxiety (10%), no interest (25%) or financial constraints 
(65%). The difference in the frequency of dental visits between groups was significant 
(p < 0.0001, chi-squared test). There was no significant difference in the frequency of 
dental visits between genders within groups. 
Sweet snacks 
Thirty-seven percent of subjects in group A and 43% of subjects in group B consumed 
one sugar-containing snack per day. Fifty-one percent of subjects in group A and 40% 
of subjects in group B ate 2–4 high-sugar snacks per day. There was no significant 
difference in the frequency of high-sugar snack consumption between groups. 
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Beverages 
Daily beverage consumption was categorized as water/tea (without sugar), soft drinks 
(carbonated drinks) and sweet drinks (iced tea, sweetened coffee or tea, and orange 
juice) (Table III). The beverage consumption of groups A and B was significantly 
different (p = 0.0078, chi-squared test). 
Cannabis use 
The participants of group A had their first experience with cannabis at a mean age of 15 
years. Of the participants in group A, 2.3% used cannabis once weekly; 25.6% used it 
several times per week, 34.9% used it once per day and 37.2% used it several times per 
day. Seventy-nine percent used cannabis only in the evening and 21% began using 
cannabis in the morning or at noon. All subjects used cannabis by smoking it; 93% 
smoked marijuana (dried leaves) and 7% smoked hash (resin and pollen). Ninety-five 
percent smoked cannabis mixed with tobacco and 5% smoked pure cannabis. The 
incidence of hunger, thirst and consumption of food and drink after the use of cannabis 
are presented in Table IV. 
Oral hygiene 
Seventy-two percent of group A subjects cleaned their teeth after using cannabis and 
28% did not. Reasons given for neglecting oral hygiene were “too tired” (84%) and 
“didn’t feel like doing that” (16%). 
Willingness to change habits 
When asked whether they would change their habits if it were proven that the risk of 
caries is increased by cannabis use, 79% of the participants of group A answered yes 
and 21% answered no. Forty-four percent of those who answered in the affirmative 
indicated that they would brush their teeth immediately after using cannabis, 44% 
indicated that they would improve their oral hygiene, 9% indicated that they would 
consume less sweets and 3% indicated that they would reduce their use of cannabis. 
When asked if they would stop smoking cannabis if it were proven that the risk of 
developing cancer is increased by cannabis use, 97% answered no and 3% answered 
yes. 
Clinical results 
The gingival indices, plaque indices and stimulated saliva flow rates for groups A and B 
were 1.26 and 1.11, 1.21 and 0.90 and 1.9 and 1.8 ml/min, respectively; there was no 
significant difference between groups. In both groups, saliva buffer capacity was 
 10 
intermediate and saliva pH was 7.0. The incidence of DFS is presented in Table V. The 
incidence of DFS was not significantly different between groups (p = 0.2112) when 
both genders were included in the analysis but differed when only males were included 
in the analysis (p = 0.0051, Mann–Witney test). 
 
The incidence of decayed surfaces (DS) is also presented in Table V. The difference 
between groups was highly significant (p < 0.0001, Mann–Witney test). The number of 
DS in males differed between groups as did those of females (males, p = 0.0001; 
females, p = 0.0016; Mann–Witney test). 
 
The clinical examination revealed a high prevalence of caries on smooth surfaces, 
which according to epidemiological data is uncommon for this age group in 
Switzerland. This was analyzed in greater detail by subdividing data according to the 
state of the lesion (initial [D1–2] or dentine [D3–4]) and its location (molars or front 
teeth) (Table VI). As groups consisted of small numbers of subjects and were not paired 
in respect of gender, these data were not subjected to statistical analysis. 
 
Discussion 
Forty-three cannabis users with additional cigarette consumption and 42 tobacco 
smokers took part in the study. The groups were paired according to age but not 
according to gender. The inclusion and exclusion criteria were chosen for the following 
reasons. Eighteen was adopted as the lower age limit because in Switzerland people 18 
years and older do not have to obtain their parents’ permission to participate in a study 
such as this. Twenty-five was chosen as the maximum age in order to limit variation in 
age. The use of other illicit drugs was chosen as an exclusion criterion to limit the 
results to those of cannabis alone. Pregnancy was chosen as an exclusion criterion 
because radiography was performed on the subjects. Weekly cannabis use was chosen 
as an inclusion criterion for the test group because COFFEY ET AL. (2003) reported that 
the most important predictors of cannabis addiction are weekly cannabis use and regular 
tobacco smoking. As all cannabis users in our study smoked at least 10 cigarettes per 
day, control group subjects who smoked at least 10 tobacco cigarettes per day were 
selected. Out of 15 examined risk factors to become a cannabis user, the following three 
were found to be the most important ones: tobacco smoking, accessibility of cannabis 
and pessimistic health prospect. If these three factors are present the probability for 
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cannabis use is 77% (SCHMID 2000). The pacemaker-hypothesis describes cannabis 
consumption as a consequence of precedent consumption of tobacco and alcohol (SFA-
ISPA 2004). All cannabis users and tobacco smokers had to have been using the 
substances for at least two years before the trial because this interval is sufficient for the 
development of carious lesions. 
 
Members of the test group started using cannabis at an average age of 15 years, which is 
in accordance with the results of MÜLLER & GMEL (2002), i.e., that teenagers begin to 
use cannabis before the age of 16. Cannabis users were initially recruited through 
advertisements in free daily newspapers. That more male (n = 28) than female (n = 15) 
cannabis users responded is in agreement with the results of SCHMID ET AL. (2003) and 
MÜLLER & GMEL (2002). 
 
Urine samples were not obtained to verify cannabis use because GMEL (1998) showed 
that self-reported cannabis use is not distorted by denial tendencies. Furthermore, urine 
analysis would only have ascertained whether participants were positive or negative for 
THC and would have provided no information on the frequency and intensity of 
cannabis use. 
 
It was difficult to balance the groups because all cannabis users recruited also smoked 
tobacco. Furthermore, 30% of potential participants did not show up for their 
examination appointment. Advertisements were placed in free daily newspapers to 
recruit age- and gender-paired tobacco smoking participants but the response was poor. 
Forty-two participants were eventually selected for the control group but there were 
fewer males (n = 14) than females (n = 28). It is unclear why the response of tobacco 
smokers to the advertisements was poor or why more females registered to participate in 
group B than in group A. Of 20–24-year-old Swiss residents, 42.2% smoke tobacco 
(SFA-ISPA 2004a); 39.9% of males and 34.8% of females smoke tobacco (GMEL ET AL. 
2006). It is thus reasonable to assume that our widespread media advertisements would 
have been seen by a considerable number of tobacco smokers. Dental awareness is very 
high in Switzerland. Of the Swiss population, 75% visit a dentist once a year and 10% 
visit a dentist twice a year (IMFELD 2000). In our study, 74% of the control group 
reported having annual dental control visits. According to a survey conducted by the 
Swiss Dental Association, 90% of participants (n = 1125) were satisfied with their 
dentist and 49% indicated that they would still visit the same dentist if they moved to a 
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different suburb (KUSTER ET AL. 2000). Therefore, it is possible that for many tobacco 
smokers, the offer of a free dental consultation and bitewing radiographs may have been 
outweighed by a desire to be treated by their own dentists. 
 
The groups were not paired in respect of education. In group A, apprenticeships 
prevailed, while in group B more participants had an academic education. Furthermore, 
tobacco consumption was not paired between genders within groups. Nevertheless, the 
study reaffirmed that cannabis use is widespread irrespective of level of education, 
which corroborates the results of MÜLLER & GMEL (2002). 
 
There are no published clinical studies on the effects of cannabis per se on oral health. 
SILVERSTEIN’S test group consisted of vegetarians who used other drugs in addition to 
cannabis; control group subjects did not use drugs or tobacco but were not vegetarians 
(SILVERSTEIN ET AL. 1978). Di Cugno compared subjects who used both cannabis and 
amphetamines with subjects who did not use these drugs (1979). The only existing 
reports on cannabis and dental health are literature reviews, not clinical studies. 
Therefore, our study is the first clinical report on cannabis use and the prevalence of 
caries in smokers. Because of the small number of participants, who were not paired in 
respect of gender, the data were insufficient to support definitive conclusions. 
Nevertheless, several noteworthy tendencies emerged. 
 
The frequency of tooth brushing and dental visits differed highly significantly (p < 
0.0001) between groups. There was no difference in the consumption of high-sugar 
snacks but there was a significant difference in the intake of sweet beverages (p≤ 
0.0078). Although these results suggest that cannabis users have a high risk of 
developing caries, plaque and gingival indices did not differ between groups. The 
incidence of DFS did not differ between groups A and B (8.07 vs. 6.76, respectively). 
When DFS data of male participants alone were analyzed, the difference between 
groups was significant (group A, 9.14; group B, 2.50; p = 0.0051). However, this 
statistic should be interpreted with caution because the number of males in the test and 
control groups differed (n = 28 and n = 15, respectively). On the other hand, the 
between-group difference in the incidence of DS was highly significant (p < 0.0001). 
More untreated lesions were present in group A than in group B. This may be 
responsible for the impression of private practitioners that cannabis users have more 
caries than those who do not use cannabis, because untreated carious lesions, especially 
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those at low-risk locations such as smooth surfaces, are a more obvious sign of caries 
than restorations. 
 
In cannabis users, carious lesions were most prevalent on smooth surfaces (Fig. 1). The 
DS results of our study were compared with data from a 2006 epidemiological caries 
survey of Swiss military recruits (Table VII). In our study, cannabis users had a higher 
prevalence of caries than military recruits, when expressed as the number of DS on 
smooth surfaces. Caries lesions on smooth surfaces are indicative of high caries activity 
because these surfaces are easily brushed. 
 
Statistical comparison of our data with that of the Swiss military recruit study was not 
done because participants in the latter study were representative of 20-year-old men and 
the dataset had a normal distribution of smokers and cannabis-using participants. 
Saliva flow rates did not differ between groups (group A, 1.8 ml/min; group B, 1.9 
ml/min), nor did pH or buffer capacity. Several authors have shown that salivation is 
reduced by atropine (CHO 2005, DARLING & ARENDORF 1992, DI CUGNO 1979, 
GROTENHERMEN 2001). In our study, 84% of the participants experienced a dry mouth 
after using cannabis and 91% felt thirsty, indicating that short-term hyposalivation 
occurs after using cannabis. There was no evidence of chronic hyposalivation, 
xerostomia or long-term reduction in buffer capacity or pH, even though 97% of the 
participants had used cannabis more than once weekly for more than two years. It would 
be of interest to examine saliva flow rate immediately after cannabis consumption. 
However, a request for study participants to use cannabis at a specific time could be 
interpreted as motivating them to use cannabis, which is illegal according to Article 19 
of the Swiss Health Statute (BetmG 2007). According to 81% of the participants, a dry 
mouth persisted for up to an hour after using cannabis; 19% reported that it lasted 
between 2 and 6 hours. Of all cannabis users, 63% ate sweet food, 31% drank sweet 
beverages (soft drinks or noncarbonated sweet drinks) after using cannabis and 28% did 
not clean their teeth after using cannabis or before sleeping (most cannabis users 
consume cannabis and sweet foods or beverages during the evening). Such behavior 
increases the risk of caries and may be aggravated by a dry mouth. 
 
That smoking cannabis may increase the risk of developing cancer (TASHKIN 1999) did 
not influence the participants’ attitude to the use of cannabis: 97% answered that they 
would not stop using cannabis despite the risk of cancer. Surprisingly, 79% indicated 
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that they would change their routine if cannabis were proven to affect their teeth, 44% 
answered that they would brush their teeth after consuming cannabis and sweet 
beverages or foods and 44% indicated that they would improve their oral hygiene. 
 
The hypothesis that cannabis increases the risk of caries was not confirmed by the 
results of this study. However, the difference between groups in the incidence of DS 
was highly significant. Cannabis users had considerably more open carious lesions than 
those who did not use cannabis. Short-term xerostomia and consumption of cariogenic 
food and beverages after using cannabis may be responsible for the high incidence of 
caries on smooth surfaces. The cariogenic diet, reduced frequency of oral hygiene and 
rare dental control visits indicate that the lifestyle of cannabis users makes an important 
contribution to the incidence of caries. Therefore, the combination of cannabis use and 
an unhealthy lifestyle increases the risk of caries on smooth surfaces. The finding that 
cannabis users indicated that they would change their oral hygiene if their addiction 
resulted in an increased risk of caries, suggests that oral health education by private 
practitioners and prophylaxis personnel would be a successful preventive measure. The 
effects of cannabis on oral health have not been thoroughly investigated. Further studies 
are needed to gain more insights into this interesting field. 
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Zusammenfassung 
Cannabis und Karies – Erhöht regelmässiger Cannabiskonsum das Kariesrisiko bei 
Zigarettenrauchern? 
Im letzten Jahrzehnt hat sich der Cannabiskonsum unter Schweizer Jugendlichen fast 
verdoppelt. Empirische Beobachtungen aus der Privatpraxis lassen vermuten, dass 
Cannabiskonsumenten mehr Karies haben als Nicht-Konsumenten. In der vorliegenden 
Studie wird untersucht, ob regelmässiger Cannabiskonsum zu einem erhöhten 
Kariesrisiko führt. Die möglichen Ursachen (1)Hyposalivation und (2)Lifestyle werden 
diskutiert. 
43 Cannabis- und 42 Tabakkonsumenten (18 bis 25jährig) wurden untersucht. Die 
Daten der Probanden wurden mittels standardisiertem Fragebogen und klinischer 
Untersuchung erfasst. 
Zwischen der Studien- und Kontrollgruppe gab es keine signifikanten Unterschiede bei 
den DFS-Werten, den Plaque- und Gingivaindices und der Speichelfliessrate. Bei den 
Cannabiskonsumenten waren der DS-Wert signifikant erhöht (p=0.0051), die tägliche 
Mundhygiene und Kontrollbesuche beim Zahnarzt signifikant seltener (p<0.0001) und 
der Konsum von Süssgetränken signifikant häufiger (p=0.0078). Die DS-Werte an 
Zahnglattflächen der männlichen Cannabiskonsumenten wurden verglichen mit den 
entsprechenden Daten der periodischen Rekrutenuntersuchung. Bei den 
Cannabiskonsumenten wurde deutlich mehr Glattflächenkaries festgestellt. 
Gemäss den DFS-Werten kann kein erhöhtes Kariesrisiko bei Cannabiskonsumenten 
gegenüber der Kontrollgruppe nachgewiesen werden. Es liegt aber eine deutlich erhöhte 
Prävalenz von Glattflächenkaries gegenüber epidemiologischen Daten vor. Der 
Lifestyle verbunden mit einer kurzfristigen Hyposalivation nach THC-Konsum wird als 
mögliche Ursache angenommen. Weitere Untersuchungen sollten den Einfluss des 
Cannabiskonsums auf die orale Gesundheit erforschen.  
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Résumé 
Cannabis et carie – la consommation régulière de cannabis augmente-t-elle le risque de 
carie des fumeurs de cigarettes? 
En Suisse, la consommation de cannabis par les adolescents a presque doublé dans les 
dernières dix années. L’observation empirique des dentistes privés prête à croire que les 
consommateurs de cannabis ont plus de caries que les non-consommateurs. La présente 
étude examine si la consommation régulière de cannabis augmente le risque de caries et 
discute les causes probables 1èrement l’hyposalivation ou 2ièmement le style de vie de ces 
jeunes gens. 
Un groupe de 43 consommateurs de cannabis et un groupe de contrôle de 42 
consommateurs (de 18 à 25ans) de tabac ont été examinés. Au moyen d’un 
questionnaire standardisé et d’un examen clinique les dates des participants ont été 
prises. 
Il n’est pas résulté de différences significatives en ce qui concerne les valeurs de DFS, 
ni pour ce qui est des tests de salive ainsi que des indices gingivaux et de plaque. Dans 
le groupe cannabis les résultats de DS étaient significativement plus élevés (p=0.0051), 
les résultats quant à l’hygiène orale quotidienne et aux visites de contrôle chez le 
dentiste étaient significativement plus mauvais (p<0.0001) et par ailleurs, les 
consommateurs de cannabis buvaient significativement plus de boissons sucrées 
(p=0.0078). Les résultats de DS aux surfaces lisses pour les hommes du groupe 
cannabis ont été comparés aux résultats corrélatifs de l’examen périodique de carie des 
recrues suisses. Chez les consommateurs de cannabis, on a constaté fortement plus de 
carie aux surfaces lisses. 
Le DFS ne permet pas de constater un risque accru de caries. Cependant il y a une 
prévalence accrue de carie aux surfaces lisses face aux dates épidémiologiques. Comme 
source probable on agrée le lifestyle embraché à l’hyposalivation à court terme après 
d’avoir consommé THC. 
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Table I. Psychological and physiological effects of cannabis (GROTENHERMEN 2001). 
 
I Psyche and perception Sedation, euphoria, dysphoria, anxiety increase and decrease, 
depersonalization, intense sensoric perception, increased 
sexual sensation, changed time-relevance, hallucinations 
 
II Cognition and the 
psychomotor system 
Fragmented thinking, distorted short-term memory and 
attention, associated thinking, increased creativity, ataxia, 
woolly language, better or worse movement coordination, 
decreased hyperkinetic movement distortion 
 
III Nervous system Analgesia, muscle relaxation, increased appetite, emesis, anti-
emesis, neuroprotection in ischemia and hypoxemia 
 
IV Body temperature Decreased body temperature 
V Cardiovascular system Tachycardia, increased heart load and oxygen need, 
vasodilatation, orthostatic hypotension, hypertension while 
lying, inhibition of thrombocytic aggregation 
VI Eye Conjunctival redness, decreased tear water, decreased 
intraocular pressure 
 
VII Respiratory system Bronchodilatation, hyposalivation with a dry mouth 
VIII Digestive system Decreased intestinal motility and gastric emptying 
 
IX Endocrine system Effect on LH, FSH, testosterone, prolactin, growth hormone, 
TSH, glucose homeostasis, decreased spermiogenesis, 
decreased sperm motility, menstrual cycle interruptions and 
inhibited ovulation 
 
X Immune system Impairment of cellular and humoral immunity, immune 
stimulation, inhibition of inflammation 
 
XI Embryo development Inhibition of growth, reduction in fetal and early brain 
development, impairment of cognitive capacity 
 
XII Genome and cancer Antineoplastic activity, inhibition of the synthesis of DNA, 
RNA and proteins 
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Table II. Daily tooth brushing in groups A and B (%). 
 
Gender Daily tooth brushing Group A Group B 
Males A Females A Males B Females B 
0 × 5 2 7 0 7 0 
1 × 42 2 43 40 7 0 
2 × 44 65 39 53 79 57 
3 × 9 31 11 7 7 43 
 
 
 
 
 
 
Table III. Beverage consumption in groups A and B (%). 
 
Main beverage Group A Group B 
Water/tea 62.8 88.1 
Soft drinks 16.3 0.0 
Sweet drinks 20.9 11.9 
 
 
 
 
 
 
Table IV. Behavior after using cannabis (%). 
 
Hungry after 
cannabis use 
Type of food 
consumed 
after using 
cannabis  
Thirsty after 
cannabis use 
Type of drink 
consumed 
after using 
cannabis 
Dry mouth after 
cannabis use 
Duration of 
dry mouth 
no 12  no 9  no 16  
sweet 63 water 69 1 h 81 
salty 37 soft 
drinks 
10 
yes 88 
sour 0 
yes 91 
sweet 
drinks 
21 
yes 84 
2–6 
h 
19 
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Table V. DFS and DS in groups A and B. 
 
Gender  Group A Group B 
Males A Females A Males B Females B 
DFS 8.07 6.76 9.14 6.07 2.50 8.48 
DS 4.88 0.74 5.61 3.53 0.42 0.87 
 
 
Table VI. Detailed DS results for groups A and B. 
 
Gender  Group A Group 
B Males A Females A Males B Females B 
D1–2 on smooth 
surfaces of molars 
0.86 0.52 0.86 0.86 0.00 0.73 
D3–4 on smooth 
surfaces of molars 
0.74 0.05 1.04 0.20 0.08 0.03 
D1–2 on smooth 
surfaces of anterior 
teeth 
0.95 0.00 1.32 0.27 0.00 0.00 
D3–4 on smooth 
surfaces of anterior 
teeth 
0.60 0.07 0.82 0.20 0.00 0.10 
 
 
Table VII. Comparison of DS results of the present study and those of a 2006 survey of 
Swiss military recruits. 
 
 Males A 
n = 28 
Males B 
n = 15 
Swiss recruits 
n = 606 
D1–2 on smooth surfaces of molars 0.86 0.00 0.59 
D3–4 on smooth surfaces of molars 1.04 0.08 0.09 
D1–2 on smooth surfaces of anterior teeth 1.32 0.00 0.44 
D3–4 on smooth surfaces of anterior teeth 0.82 0.00 0.12 
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Fig. 1. Carious lesions on smooth surfaces in an 18-year-old cannabis user. 
 
 
 
 
